Table 5

Vitamin D status and nutritional parameters in patients with tuberculosis

OutcomeBody mass index (kg/m2)Albumin concentration (g/dL)Haemoglobin concentration (g/dL)
Adequate vitamin D, mean (SD)*Vitamin D insufficiency, mean difference (95% CI)†Vitamin D insufficiency, adjusted mean difference (95% CI)‡p ValueAdequate vitamin D, mean (SD)*Vitamin D insufficiency, mean difference (95% CI)†Vitamin D insufficiency, adjusted mean difference (95% CI)‡p ValueAdequate vitamin D, mean (SD)*Vitamin D insufficiency, mean difference (95% CI)†Vitamin D insufficiency, adjusted mean difference (95% CI)‡p Value
Entire follow-up: all patients
 Vitamin D insufficiency (<75 nmol/L)21.20 (2.80)−0.06 (−0.30 to 0.17)−0.08 (−0.30 to 0.14)0.463.42 (0.74)−0.05 (−0.14 to 0.04)0.00 (−0.08 to 0.08)0.9712.65 (1.80)−0.16 (−0.40 to 0.08)−0.18 (−0.41 to 0.05)0.12
 Vitamin D deficient (<50 nmol/L)21.23 (3.00)−0.16 (−0.46 to 0.14)−0.14 (−0.44 to 0.15)0.343.42 (0.72)−0.05 (−0.17 to 0.07)0.02 (−0.08 to 0.13)0.6512.42 (1.87)0.15 (−0.16 to 0.45)0.17 (−0.11 to 0.45)0.24
 Continuous vitamin D (per nmol/L)0.00 (0.00 to 0.01)0.00 (0.00 to 0.01)0.300.002 (0.00 to 0.004)0.000 (−0.002 to 0.002)0.90 0.00 (−0.01 to 0.01)0.00 (0.00 to 0.01)0.85
First 8 months of follow-up: all patients
 Vitamin D insufficiency (<75 nmol/L)20.96 (2.73)−0.20 (−0.40 to −0.01)−0.21 (−0.39 to −0.02)0.033.42 (1.09)−0.01 (−0.18 to 0.16)0.04 (−0.13 to 0.21)0.6512.12 (1.85)−0.01 (−0.28 to 0.26)−0.04 (−0.31 to 0.23)0.78
 Vitamin D deficient (<50 nmol/L)20.85 (2.84)0.00 (−0.25 to 0.25)0.04 (−0.21 to 0.29)0.783.41 (1.08)−0.11 (−0.32 to 0.10)−0.05 (−0.27 to 0.17)0.6411.92 (1.99)0.16 (−0.18 to 0.50)0.21 (−0.10 to 0.53)0.19
 Continuous vitamin D (per nmol/L)0.00 (0.00 to 0.01)0.00 (0.00 to 0.01)0.38 0.000 (−0.003 to 0.005)0.000 (−0.004 to 0.004)0.87 0.00 (−0.01 to 0.00)0.00 (−0.01 to 0.00)0.57
  • * Data are the means (SD) of the average measurement during follow-up for each participant.

  • † Data are the mean difference between the low and the adequate vitamin D group. The mean differences, 95% CIs and corresponding p values were estimated from generalised estimating equations, after adjustment for baseline measurements, follow-up time and treatment (micronutrients vs placebo) group.

  • ‡Multivariate analyses additionally adjusted for age, Karnofsky score, baseline haemoglobin, viral load, CD4 T cell count and HIV status; HIV status removed from the model where the results are stratified by HIV status. Viral load also removed from the model in HIV-uninfected individuals.